Molecular diagnostics market & forecast (by application, technology, countries, companies & clinical trials) to 2017
Upcoming SlideShare
Loading in...5
×
 

Molecular diagnostics market & forecast (by application, technology, countries, companies & clinical trials) to 2017

on

  • 1,458 views

Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of ...

Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering

Statistics

Views

Total Views
1,458
Slideshare-icon Views on SlideShare
1,458
Embed Views
0

Actions

Likes
0
Downloads
33
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Molecular diagnostics market & forecast (by application, technology, countries, companies & clinical trials) to 2017 Molecular diagnostics market & forecast (by application, technology, countries, companies & clinical trials) to 2017 Document Transcript

    • Molecular Diagnostics Market & Forecast (ByApplication, Technology, Countries, Companies & ClinicalTrials) to 2017: Global AnalysisRenub Researchwww.renub.comPublished: April, 2013Copyright © 2013 Renub Research – All Rights Reserved
    • Global Molecular Diagnostics Market & Future Forecast to 2017 OverviewThe global molecular diagnostics market is witnessing a period of profound growth. The growthis coming from different regions and markets. The next five years will witness significantdevelopments in molecular diagnostics such as automation, as well as introduction of a widerange of new products. Molecular Diagnostics involves multiple technologies to identify geneticvariations in individual patients. These technologies include PCR, FISH, hybrid capture,sequencing and microarrays. The increase in the aging population and incidences of variouschronic diseases are driving the demand of molecular diagnostics world over. The industry isgetting a push from every side and many factors collectively are fuelling the growth in thisindustry. Growing with a CAGR of 14.64 percent global molecular diagnostics market isexpected to double its market size in 2017 from the market of 2012.Molecular Diagnostics Market - Application Segment Analysis The infectious disease testing is the leading application in Molecular Diagnostic. It islikely to hold XXXX% share in 2017. Molecular oncology tests have emerged as a second significant rapidly growing marketsegment. Genetic Testing and Blood Screening are at the third and fourth spotrespectively in 2012. The cardiovascular disease testing and neurological testing are closely competing witheach other to gain the maximum market share. Food testing market is expected to inch up to US$ XXXX Million in 2017.Molecular Diagnostics Market - Technologies Segment Analysis Biochips and PCR based test accounts for the largest shares in the molecular diagnosticstechnologies segment with XXXX% and XXXX% respectively in 2012. Fish & Innovations technology market is at the 3rdslot.
    • © Renub Research Page 3 of 21 The PCR related technologies and Non- PCR market is at the 4thand 5thpositionrespectively. The biosensor and Molecular Imaging technology are also showing impressive growth.Molecular Diagnostics Market - Geographical Analysis United States molecular diagnostic market is expected to be more than double by 2017from its current market in 2012. Europe stands at the second position in the global molecular diagnostic market. China, Japan and India are expected to stand at 3rd, 4thand 5thslot respectively. The Mexico molecular diagnostics market is predicted to grow at a CAGR of 17%between 2012 and 2017.Molecular Diagnostics Market – Company Wise Analysis The Roche molecular diagnostic share is greater than the combined share of MyriadGenetics and Qiagen which holds the 2ndand 3rdposition respectively. Abbott stands at the 4thspot and expected to generate sales worth US$ XXXX Million bythe year 2017. The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.Renub Research study titled “Molecular Diagnostics Market & Forecast (By Application,Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis” provides acomprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnosticsmarket. This 157 page report with 81 Figures and 23 Tables studies the Global MolecularDiagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) GeographicalMarket & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular
    • © Renub Research Page 4 of 21Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trialsIn Molecular Diagnostics Landscape.The Report Covers the Following Points Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017) Global Molecular Diagnostic Application Segment (Infectious Disease Testing, VirologyTesting, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening,Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing,Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market(2010-2012) and Forecast (2013 to 2017) Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies ,Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, MolecularImaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017) Molecular Diagnostic Geographical Distribution (US, Europe, China, Japan, India, Brazil,Mexico, South Korea and Rest of World) Market (2010-2012) and Forecast (2013 to 2017) Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics,Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017) Molecular Diagnostic and Road to Personalized medicine Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report) Driving Forces & Challenges for Global Molecular Diagnostic MarketData SourcesThis report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Renub Research team of industry experts.
    • © Renub Research Page 5 of 21Primary sources include industry surveys and telephone interviews with industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals,White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,Industry Portals, Industry Associations and access to more than 100 paid databases.
    • © Renub Research Page 6 of 21About UsRReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company withcenters at Noida India and Roswell USA. We have long-term experience especially ininternational Business-to-Business Researches, Surveys, Business and Consulting. Throughoutthe years we have acquired expertise in most market sectors, including Information Technology(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, ConsumerGoods, Logistics, Governmental, Social, and Others.Our core team is comprised of an experienced people holding graduate, post graduate andPh.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, InformationTechnology, Environmental Science and many more. Our research help make the businessdecisions: on strategy, organization, operations, technology, mergers & acquisitions etc. Wesupport many blue chip companies by providing them findings and perspectives across a widerange of markets. Our research reports offer a blend of information insight, analysis andforecasting that is essential in today’s ultra-competitive markets.For more information on us or to view any of our sample work you can mailus at info@renub.com
    • © Renub Research Page 7 of 21PublishedByRReennuubb RReesseeaarrcchhA–116B, Sector–27Noida – 201301Phone: +91-120-421-9822, 254-5750 (India)+1-678-302-0700 (USA)Fax : +91-120-424-9780Email: info@renub.comwww.renub.com© Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies& Clinical Trials) to 2017: Global AnalysisRenub Research, 2013Edition 1.0All rights reserved. This publication is protectedby copyright. No part of it may be reproduced, storedin a retrieval system or transmitted, in any form or byany means, electronic mechanical, photocopying,recording or otherwise without the prior writtenpermission of the publishers
    • © Renub Research Page 8 of 21Table of Contents1. Executive Summary2. Molecular Diagnostics Market & Forecast – (2010 – 2017)3. Molecular Diagnostics Market Share – (2010 – 2017)3.1 Molecular Diagnostics Market Share & Forecast – Application Wise3.2 Molecular Diagnostics Market Share & Forecast – Technology Wise3.3 Molecular Diagnostics Market Share & Forecast – Region Wise3.4 Molecular Diagnostics Market Share & Forecast – Company Wise4. Molecular Diagnostics Market (Application Segment) – (2010 – 2017)4.1 Infectious Disease Testing Market & Forecast4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast4.1.2 Health – Associated Infections (HAI) Testing Market & Forecast4.1.3 HPV Testing Market & Forecast4.1.4 Critical Care Infectious Testing Market & Forecast4.2 Blood Screening Market & Forecast4.3 Genetic Testing Market & Forecast4.4 Oncology Testing Market & Forecast4.5 Tissue Typing (HLA Testing) Market & Forecast4.6 Cardiovascular Disease Testing Market & Forecast4.7 Neurological Disorders Testing Market & Forecast4.8 Food Pathogen Detection Testing Market & Forecast4.9 Miscellaneous Testing Market & Forecast5. Molecular Diagnostics Market (Technologies Segment) – (2010 – 2017)5.1 PCR Based Test Market & Forecast5.2 PCR Related Technologies Market & Forecast5.3 Non-PCR Test Market & Forecast5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast5.5 Biochips/Microarrays Market & Forecast5.6 Biosensors Market & Forecast
    • © Renub Research Page 9 of 215.7 Molecular Imaging Market & Forecast5.8 Other Technologies Market & Forecast6. Geographical Distribution – Molecular Diagnostics Market – (2008 – 2017)6.1 United States Molecular Diagnostics Market & Forecast6.2 Europe Molecular Diagnostics Market & Forecast6.3 China Molecular Diagnostics Market & Forecast6.4 Japan Molecular Diagnostics Market & Forecast6.5 India Molecular Diagnostics Market & Forecast6.6 Brazil Molecular Diagnostics Market & Forecast6.7 Mexico Molecular Diagnostics Market & Forecast6.8 South Korea Molecular Diagnostics Market & Forecast6.9 Rest of World Molecular Diagnostics Market & Forecast7. Molecular Diagnostics Market (Company Wise) – (2010 – 2017)7.1 Roche Molecular Diagnostics Market & Forecast7.2 Abbott Molecular Diagnostics Market & Forecast7.3 Myriad Genetics Molecular Diagnostics Market & Forecast7.4 Qiagen Molecular Diagnostics Market & Forecast7.5 BioMérieux Molecular Diagnostics Market & Forecast7.6 Other Companies Molecular Diagnostics Market & Forecast8. Molecular Diagnostics and Personalized Medicine8.1 Road to Personalized Medicine8.1.1 Historical perspective: HIV & Oncology8.1.2 Other Applications: Met & Unmet Therapy Areas8.2 Molecular Diagnostics Technologies8.2.1 Expression Profiling - RNA & Pharmacogenomics8.2.2 Expression Profiling - Proteins & Pharmacoproteomics8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis8.2.4 DNA Sequence Profiling - High-Throughput Sequencing8.3 Molecular Diagnostics and Personalized Medicine: Value-Assessed Opportunities for MultipleStakeholders Values, Needs & Expectations
    • © Renub Research Page 10 of 218.4 Regulatory Authorities8.5 Molecular Diagnostics as Companion Diagnostics: Value-Driven Adoption8.5.1 Behavioral Impact8.5.2 Economic Impact (Value-Based vs. Cost-Plus Pricing)9. Molecular Diagnostics Clinical Trial Statement9.1 Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples9.2 Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase(ALK) Translocation9.3 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus9.4 Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler9.5 A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test9.6 Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-HodgkinLymphoma9.7 Biopsies of Cancer Patients for Tumor Molecular Characterization9.8 Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSABacteremia9.9 Collection of Tissue Samples for Cancer Research9.10 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma9.11 Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia9.12 Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy9.13 Congenital Muscle Disease Study of Patient and Family Reported Medical Information9.14 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine NeedleAspirates9.15 Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia(CML) Patients in Chronic Phase9.16 CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib9.17 Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile9.18 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients9.19 Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic MyeloidLeukemia Chronic Phase Patients
    • © Renub Research Page 11 of 219.20 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)10. Molecular Diagnostics Market – Drivers10.1 Various Developments in the Molecular Diagnostics Landscape10.2 Increasing Investment in Genomics & Proteomics Research10.3 Technological Advances in Molecular Diagnostics10.4 Increasing Acceptance of the Personalized Medicine10.5 Growing Molecular Diagnostics for Food Safety11. Molecular Diagnostics Market – Challenges11.1 Regulatory Issues11.2 Various Factors Slowing Growth of Molecular Diagnostics11.3 Reimbursement Capabilities11.4 Quality Checkpoints, Awareness & Acceptance
    • © Renub Research Page 12 of 21List of Figures:Figure 2-1: Global – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 2-2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 3-1: Global Molecular Diagnostics – Application Wise Market Share (Percent), 2010 – 2012Figure 3-2: Global Molecular Diagnostics – Forecast for Application Wise Market Share (Percent), 2013 –2017Figure 3-3: Global Molecular Diagnostics – Technology Wise Market Share (Percent), 2010 – 2012Figure 3-4: Global Molecular Diagnostics – Forecast for Technology Wise Market Share (Percent), 2013 –2017Figure 3-5: Global Molecular Diagnostics – Region Wise Market Share (Percent), 2010 – 2012Figure 3-6: Global Molecular Diagnostics – Forecast for Region Wise Market Share (Percent), 2013 – 2017Figure 4-1: Global – Infectious Disease Testing Market (Million US$), 2010 – 2012Figure 4-2: Global – Forecast for Infectious Disease Testing Market (Million US$), 2013 – 2017Figure 4-3: Global – Virology Testing Market (Million US$), 2010 – 2012Figure 4-4: Global – Forecast for Virology Testing Market (Million US$), 2013 – 2017Figure 4-5: Global – HAI Testing Market (Million US$), 2010 – 2012Figure 4-6: Global – Forecast for HAI Testing Market (Million US$), 2013 – 2017Figure 4-7: Global – HPV Testing Market (Million US$), 2010 – 2012Figure 4-8: Global – Forecast for HPV Testing Market (Million US$), 2013 – 2017Figure 4-9: Global – Critical Care Infectious Testing Market (Million US$), 2008 – 2012Figure 4-10: Global – Forecast for Critical Care Infectious Testing Market (Million US$), 2013 – 2017Figure 4-11: Global – Blood Screening Market (Million US$), 2007 – 2012Figure 4-12: Global – Forecast for Blood Screening Market (Million US$), 2013 – 2017Figure 4-13: Global – Genetic Testing Market (Million US$), 2010 – 2012Figure 4-14: Global – Forecast for Genetic Testing Market (Million US$), 2013 – 2017Figure 4-15: Global – Oncology Market (Million US$), 2010 – 2012Figure 4-16: Global – Forecast for Oncology Market (Million US$), 2013 – 2017Figure 4-17: Global – Tissue Typing Market (Million US$), 2008 – 2012Figure 4-18: Global – Forecast for Tissue Typing Market (Million US$), 2013 – 2017Figure 4-19: Global – Cardiovascular Disease Testing Market (Million US$), 2010 – 2012Figure 4-20: Global – Forecast for Cardiovascular Disease Testing Market (Million US$), 2013 – 2017Figure 4-21: Global – Neurological Disorders Testing Market (Million US$), 2010 – 2012Figure 4-22: Global – Forecast for Neurological Disorders Testing Market (Million US$), 2013 – 2017Figure 4-23: Global – Food Pathogen Detection Testing Market (Million US$), 2010 – 2012Figure 4-24: Global – Forecast for Food Pathogen Detection Testing Market (Million US$), 2013 – 2017Figure 4-25: Global – Miscellaneous Testing Market (Million US$), 2010 – 2012
    • © Renub Research Page 13 of 21Figure 4-26: Global – Forecast for Miscellaneous Testing Market (Million US$), 2013 – 2017Figure 5-1: Global – PCR Based Test Market (Million US$), 2010 – 2012Figure 5-2: Global – Forecast for PCR Based Test Market (Million US$), 2013 – 2017Figure 5-3: Global – PCR Related Technologies Market (Million US$), 2010 – 2012Figure 5-4: Global – Forecast for PCR Related Technologies Market (Million US$), 2013 – 2017Figure 5-5: Global – Non-PCR Test Market (Million US$), 2010 – 2012Figure 5-6: Global – Forecast for Non-PCR Test Market (Million US$), 2013 – 2017Figure 5-7: Global – Fish & Innovations Market (Million US$), 2010 – 2012Figure 5-8: Global – Forecast for Fish & Innovations Market (Million US$), 2013 – 2017Figure 5-9: Global – Biochips/ Microarrays Market (Million US$), 2010 – 2012Figure 5-10: Global – Forecast for Biochips/Micrroarrays Market (Million US$), 2013 – 2017Figure 5-11: Global – Biosensors Market (Million US$), 2010 – 2012Figure 5-12: Global – Forecast for Biosensors Market (Million US$), 2013 – 2017Figure 5-13: Global – Molecular Imaging Market (Million US$), 2010 – 2012Figure 5-14: Global – Forecast for Molecular Imaging Market (Million US$), 2013 – 2017Figure 5-15: Global – Other Technologies Market (Million US$), 2010 – 2012Figure 5-16: Global – Forecast for Other Technologies Market (Million US$), 2012 – 2017Figure 6-1: US – Molecular Diagnostics Market (Million US$), 2002 – 2012Figure 6-2: US – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-3: Europe – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6-4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-5: China – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6-6: China – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-7: Japan – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6-8: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-9: India – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6-10: India – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-11: Brazil – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6-12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-13: Mexico – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6-14: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-15: South Korea – Molecular Diagnostics Market (Million US$), 2005 – 2012Figure 6-16: South Korea – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6-17: Rest of World – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6-18: Rest of World – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 7-1: Roche – Molecular Diagnostics Sales (Million US$), 2008 – 2012Figure 7-2: Roche – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
    • © Renub Research Page 14 of 21Figure 7-3: Abbott – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7-4: Abbott – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7-5: Myriad Genetics – Molecular Diagnostics Sales (Million US$), 2007 – 2012Figure 7-6: Myriad Genetics – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7-7: Qiagen – Molecular Diagnostics Sales (Million US$), 2009 – 2012Figure 7-8: Qiagen – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7-9: BioMérieux – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7-10: BioMérieux – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7-11: Other Companies – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7-12: Other Companies – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 8-1: A Healthcare ‘Value-Net’
    • © Renub Research Page 15 of 21List of Tables:Table 3-1: Global Molecular Diagnostics – Company Wise Market Share (Percent), 2010 – 2012Table 3-2: Global Molecular Diagnostics – Forecast for Company Wise Market Share (Percent), 2013 –2017Table 8-1: Molecular Platforms for Companion DiagnosticsTable 9-1: Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples – Clinical Trials,2012Table 9-2: Crizotinib Efficacy in Non-Small Cell Lung Cancer Patients with Anaplastic Lymphoma KinaseTranslocation – Clinical Trials, 2012Table 9-3: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus – ClinicalTrials, 2012Table 9-4: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of theAMLProfiler – Clinical Trials, 2012Table 9-5: A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test –Clinical Trials, 2013Table 9-6: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-HodgkinLymphoma – Clinical Trials, 2012Table 9-7: Biopsies of Cancer Patients for Tumor Molecular Characterization – Clinical Trails, 2012Table 9-8: Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associatedMRSA Bacteremia – Clinical Trials, 2013Table 9-9: Collection of Tissue Samples for Cancer Research – Clinical Trials, 2012Table 9-10: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma – Clinical Trials, 2012Table 9-11: Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia –Clinical Trials, 2012Table 9-12: Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy, 2013Table 9-13: Congenital Muscle Disease Study of Patient and Family Reported Medical Information –Clinical Trials, 2013Table 9-14: Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine NeedleAspirates – Clinical Trials, 2013Table 9-15: Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia(CML) Patients in Chronic Phase – Clinical Trials, 2012Table 9-16: CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib – Clinical Trial, 2013Table 9-17: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile –Clinical Trials, 2013Table 9-18: Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients –Clinical Trials, 2012
    • © Renub Research Page 16 of 21Table 9-19: Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic MyeloidLeukemia Chronic Phase Patients – Clinical Trials, 2012Table 9-20: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) – Clinical Trials,2012
    • © Renub Research Page 17 of 21Related ReportsPoint of Care Testing Market and Forecast to 2016: Global AnalysisPediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide AnalysisWestern Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)Asia Medical Tourism Analysis and Forecast to 2015Clinical Chemistry Market Report & Forecast (2012 – 2015): Global AnalysisHepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016Influenza Vaccine Market Opportunities and Challenges: Worldwide ForecastGenetic Testing Market and Forecast - Global Analysis 2010 – 2015USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)Global Osteoporosis Market & Drugs Analysis 2010 – 2015Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)Global Molecular Diagnostics Market & Future Forecast 2010 - 2014Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & DrugsAnalysisGlobal Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 – 2014)Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,Challenges & Future Forecast
    • © Renub Research Page 18 of 21Our Partial List of ClientsBainWAKE Technology Services, Inc.PSS World MedicalRelypsaC&K componentsKonkuk UniversityResoneticsSamsungSEKISUI MEDICAL CO. LTD.Plentyoffish Media INCArthur D Little GmbhMorgan StanleyTakeda Pharmaceutical CorporationHokkai School of CommerceMinistry of Manpower SingaporeGenOmind, LLC.Goldman Sachs & CoNTT Advanced TechnologyTokyo Womens Medical UniversityThe Chemo-Sero-Therapeutic ResearchTrade Council of IcelandJpmorgan, Ets TradingGE Healthcare ITixia communicationsRedbusBecton DickinsonPfizerIntercellSanofi PasteurStanford BurgessPequot CapitalDMITransgene S.A.ixia communicationsToyota Tsusho Amercia Inc.National Health Research InstitutesAbbott Diabetes CareCorning Incorporated - Life SciencesL.E.K. Consulting GmbHSyntironMediVas LLCCredit SuisseDune MedicalQIAGENInje UniversityMapp BiopharmaceuticalInstitute for Information IndustryNorDiag ASARep e Inv Medicas SA deInnogenetics
    • © Renub Research Page 19 of 21Order FormScan and e-mail this page to info@renub.com, alternatively one can also write the ContactInformation in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail toinfo@renub.comFormatReport Title: Molecular Diagnostics Market & Forecast (By Application, Technology, Countries,Companies & Clinical Trials) to 2017: Global AnalysisSingle User(Email from Publisher)Hard Copy(Mail Delivery)CD – Rom(Mail Delivery)Global Site License(Multiple User License)US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200For ordering this report: Three easy ways to place your order:1) Order online by Credit Card (Visa, MasterCard, etc.):http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-1142) Order by Wire Transfer:http://renub.com/report/wiretransfer.aspx?id=114&pid=1441To pay by Wire Transfer, please, fill in your contact details in the form below:
    • © Renub Research Page 20 of 21Bank DetailsAccount Name: Renub ResearchA/C No.: 109102000023296Name of Bank: IDBI Bank Ltd.Swift Code: IBKLINBB010Bank Address: 4thFloorIndian Red Cross Building1 Red Cross RoadOpposite Parliament StreetNew Delhi – 110001IndiaContact InformationFirst Name: Last Name:Email:Job Title:Company:Address:City:Postal/Zip Code:Country:Phone:Mobile:Fax:Report Format:Your message:
    • © Renub Research Page 21 of 213) Order by CheckPlease post the check accompanied by this form, to:Company Address: Renub ResearchA -116BSector -27Noida - 201301Uttar PradeshIndiaPhone: +91-120-421-9822, 424-9780For free Sample copy report or to view any of our sample work please contact us atinfo@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)Follow UsFacebook: http://www.facebook.com/pages/Renub-Research/233380966701090LinkedIn: http://www.linkedin.com/company/renub-researchTwitter: http://twitter.com/RenubResearch